Significant Ownership of Murchinson Ltd.

Signature - Title
/s/ Marc Bistricer - Marc Bistricer, Chief Executive Officer
Location
Toronto
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Murchinson Ltd..

Follow Filing Activity

Follow Murchinson Ltd. and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of Murchinson Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 9.1% $7,840,000 280,000 Murchinson Ltd. 30 Sep 2025

Schedules 13D/G Reported by Murchinson Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .